22 Hrs
Source:
الوسط
Al-Jahra Food Inspection Reveals Violations
The article discusses a pharmaceutical company's announcement of its new internal system called "Omnipod 5" designed to help type 1 diabetes patients better control their blood sugar levels. The system is expected to improve disease management and reduce risks associated with blood sugar fluctuations. It aims to enhance patients' quality of life through advanced monitoring technologies and automatic insulin dose adjustments. Projections indicate that the use of this system may continue until 2026, with ongoing improvements and expanded capabilities. Currently, it is undergoing studies and evaluations to ensure its effectiveness and safety.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)